Villafuerte, Julieta .
HRN: 27-87-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2025
LEVOFLOXACIN 500MG (TAB)
10/05/2025
10/09/2025
PO
500 Mg/tab, 1 Tab
Od
Cap-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes